Daewoong Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewoong Company Limited with three other
companies in this sector in South Korea:
Hanmi Pharmaceutical., Company Limited
sales of 882.72 billion Korean Won [US$828.88 million]
of which 77%
Kwang Dong Pharmaceutical Company Limited
(1.06 trillion Korean Won [US$991.99 million]
of which 41%
was Food Product Operations), and
Daewoong Pharmaceutical Company Limited
(883.92 billion Korean Won [US$830.00 million]
of which 100%
was Medicine Manufacture&Sale).
During the year ended December of 2016, sales at
Daewoong Company Limited were 1.02 trillion Korean Won (US$953.10 million).
a very small
increase of 1.8%
versus 2015, when the company's sales were 996.65 billion Korean Won.
This was the fifth consecutive year of sales increases at Daewoong Company Limited
(and since 2011, sales have increased a total of 275%).
Sales of Medicinal Manufacturing and Selling saw an increase
that was more than double the company's growth rate: sales were up
10.3% in 2016, from
1.05 trillion Korean Won to 1.15 trillion Korean Won.
Daewoong Company Limited also saw significant increases in sales in
Real Estate Leasing (up 3.2% to 9.90 billion Korean Won)
Not all segments of Daewoong Company Limited experienced an increase in sales in 2016:
sales of Other fell 19.3% to 2.79 billion Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).
Daewoong Company Limited also experienced decreases in sales in
Services (down 5.7% to 73.46 billion Korean Won)